Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Combined transversus thoracic + serratus anterior plane blocks versus erector spinae plane block for pain after sternotomy

Official title: STERNOTOMİ AĞRISININ YÖNETİMİNDE TRANSVERSUS TORASİK PLAN BLOK VE SERRATUS ANTERİOR PLAN BLOK KOMBİNASYONU İLE EREKTÖR SPİNA PLAN BLOK ETKİNLİĞİNİN KARŞILAŞTIRILMASI

Run by Uludag University · NCT07452627 · Data updated 2026-11-12

This trial will try whether combining transversus thoracic and serratus anterior plane nerve blocks controls pain after median sternotomy better than an erector spinae plane block in adults having elective heart surgery.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment50 (estimated)
SponsorUludag University
Academic / other
Locations1 site (Bursa, Nilüfer)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedNovember 1, 2026
Study endsDecember 2026
Registry record updatedMarch 10, 2026
Trial IDNCT07452627 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with ASA physical status I–III scheduled for elective cardiac surgery via median sternotomy who can give informed consent and have no contraindications to regional anesthesia.

Probably not a fit

Patients who are pregnant, have BMI >35 kg/m², coagulopathy, infection at the injection site, allergy to local anesthetics, or severe neurological/psychiatric/hepatic/renal failure were excluded and are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, observer-blinded trial enrolling 50 adults (age 18–80, ASA I–III) undergoing elective median sternotomy for cardiac surgery. Participants are randomized 1:1 to receive either combined transversus thoracic plane block (TTPB) plus serratus anterior plane block (SAPB) or a single erector spinae plane block (ESPB), performed under ultrasound guidance after induction and before incision. Anesthesia and perioperative care are standardized and postoperative data collectors are blinded to the allocated block to reduce bias. Primary outcomes focus on postoperative pain control and opioid requirements, with monitoring for respiratory and other complications.

Why it matters

Potential benefit: If successful, the combined block approach could reduce postoperative sternotomy pain and opioid use, potentially improving recovery and lowering pulmonary complications.

How similar studies have gone: Regional chest wall blocks such as ESPB and SAPB have shown promising pain-reducing effects in small trials, but combining TTPB with SAPB for sternotomy pain is less well studied and remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 18 and 80 years.
* Patients with American Society of Anesthesiologists (ASA) physical status I, II, or III.
* Patients who provide written informed consent.
* Patients scheduled for cardiac surgery via elective sternotomy.

Exclusion Criteria:

* Pregnancy or suspected pregnancy
* Body Mass Index (BMI) \> 35 kg/m²
* History of allergy to local anesthetics or opioids
* Suspected coagulopathy or infection at the injection site
* Severe neurological, psychiatric, hepatic, or renal failure

Where it's running

  • Bursa Uludag University Hospital
    Bursa, Nilüfer, Turkey (Türkiye)
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.